JP2022046669A5 - - Google Patents

Download PDF

Info

Publication number
JP2022046669A5
JP2022046669A5 JP2021211779A JP2021211779A JP2022046669A5 JP 2022046669 A5 JP2022046669 A5 JP 2022046669A5 JP 2021211779 A JP2021211779 A JP 2021211779A JP 2021211779 A JP2021211779 A JP 2021211779A JP 2022046669 A5 JP2022046669 A5 JP 2022046669A5
Authority
JP
Japan
Prior art keywords
sample
assay
subject
recovery
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021211779A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022046669A (ja
JP7217796B2 (ja
Filing date
Publication date
Priority claimed from JP2020185705A external-priority patent/JP7002623B2/ja
Application filed filed Critical
Publication of JP2022046669A publication Critical patent/JP2022046669A/ja
Publication of JP2022046669A5 publication Critical patent/JP2022046669A5/ja
Priority to JP2023008480A priority Critical patent/JP2023052587A/ja
Application granted granted Critical
Publication of JP7217796B2 publication Critical patent/JP7217796B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021211779A 2014-10-20 2021-12-27 腎障害および腎不全の診断および予後のための方法および組成物 Active JP7217796B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023008480A JP2023052587A (ja) 2014-10-20 2023-01-24 腎障害および腎不全の診断および予後のための方法および組成物

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462066316P 2014-10-20 2014-10-20
US201462066313P 2014-10-20 2014-10-20
US201462066310P 2014-10-20 2014-10-20
US62/066,310 2014-10-20
US62/066,313 2014-10-20
US62/066,316 2014-10-20
JP2020185705A JP7002623B2 (ja) 2014-10-20 2020-11-06 腎障害および腎不全の診断および予後のための方法および組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020185705A Division JP7002623B2 (ja) 2014-10-20 2020-11-06 腎障害および腎不全の診断および予後のための方法および組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023008480A Division JP2023052587A (ja) 2014-10-20 2023-01-24 腎障害および腎不全の診断および予後のための方法および組成物

Publications (3)

Publication Number Publication Date
JP2022046669A JP2022046669A (ja) 2022-03-23
JP2022046669A5 true JP2022046669A5 (enExample) 2022-07-08
JP7217796B2 JP7217796B2 (ja) 2023-02-03

Family

ID=55761743

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2017521231A Active JP6792553B2 (ja) 2014-10-20 2015-10-20 腎障害および腎不全の診断および予後のための方法および組成物
JP2020185705A Active JP7002623B2 (ja) 2014-10-20 2020-11-06 腎障害および腎不全の診断および予後のための方法および組成物
JP2021211779A Active JP7217796B2 (ja) 2014-10-20 2021-12-27 腎障害および腎不全の診断および予後のための方法および組成物
JP2023008480A Pending JP2023052587A (ja) 2014-10-20 2023-01-24 腎障害および腎不全の診断および予後のための方法および組成物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2017521231A Active JP6792553B2 (ja) 2014-10-20 2015-10-20 腎障害および腎不全の診断および予後のための方法および組成物
JP2020185705A Active JP7002623B2 (ja) 2014-10-20 2020-11-06 腎障害および腎不全の診断および予後のための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023008480A Pending JP2023052587A (ja) 2014-10-20 2023-01-24 腎障害および腎不全の診断および予後のための方法および組成物

Country Status (13)

Country Link
US (2) US11333671B2 (enExample)
EP (2) EP3968022A1 (enExample)
JP (4) JP6792553B2 (enExample)
KR (1) KR102431003B1 (enExample)
CN (2) CN107003301B (enExample)
AU (2) AU2015336069B2 (enExample)
BR (1) BR112017008218A2 (enExample)
CA (1) CA2965153C (enExample)
EA (1) EA201790696A1 (enExample)
ES (1) ES2907551T3 (enExample)
MX (1) MX388231B (enExample)
PT (1) PT3210018T (enExample)
WO (1) WO2016064877A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX388231B (es) 2014-10-20 2025-03-19 Astute Medical Inc Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal.
EP4063853A1 (en) * 2017-01-12 2022-09-28 Astute Medical, Inc. Methods and compositions for evaluation and treatment of renal injury and renal failure based on c-c motif chemokine ligand 14 measurement
US11346846B2 (en) 2017-02-06 2022-05-31 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3732196A4 (en) 2017-12-28 2022-01-05 Astute Medical, Inc. ANTIBODIES AND ASSAYS FOR CCL14
AU2019249070B2 (en) * 2018-04-02 2024-06-13 Potrero Medical, Inc. Systems, devices and methods for draining and analyzing bodily fluids and assessing health
US12114978B2 (en) 2018-04-02 2024-10-15 Potrero Medical, Inc. Systems, devices and methods for draining and analyzing bodily fluids and assessing health
US20220236285A1 (en) * 2019-05-24 2022-07-28 Astute Medical, Inc. Methods for evaluation and treatment of renal injury based on c-c motif chemokine ligand 14 measurement
US20230290457A1 (en) * 2020-03-23 2023-09-14 Biocogniv Inc. Artificial intelligence medical device
GB2596142B (en) * 2020-06-19 2023-11-29 Secr Defence Methods and associated uses, kits and systems for assessing sepsis
AU2021381364A1 (en) * 2020-11-18 2023-06-22 Astute Medical, Inc. Methods and compositions for treatment of renal injury and renal failure

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
WO1992005282A1 (en) 1990-09-14 1992-04-02 Biosite Diagnostics, Inc. Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
ATE177841T1 (de) 1991-04-10 1999-04-15 Biosite Diagnostics Inc ''crosstalk''- oder übersprech-inhibitoren und ihre verwendung
EP0579767B1 (en) 1991-04-11 2000-08-23 Biosite Diagnostics Inc. Novel conjugates and assays for simultaneous detection of multiple ligands
US5885527A (en) 1992-05-21 1999-03-23 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membrances
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6811773B1 (en) * 1993-12-22 2004-11-02 Human Genome Sciences, Inc. Human monocyte colony inhibitory factor (M-CIF) polypeptides
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
US20030157573A1 (en) 2002-02-12 2003-08-21 Orna Mor Use of Axl receptor for diagnosis and treatment of renal disease
US20120064089A1 (en) * 2002-11-15 2012-03-15 Morehouse School Of Medicine Anti-cxcl16 and anti-cxcr6 antibodies for the prevention and treatment of cancer and cancer cell migration
US7833732B2 (en) 2005-07-21 2010-11-16 The John Hopkins University Acute renal injury
EP1996013A4 (en) 2005-09-21 2010-03-10 Dask Technologies Llc METHODS AND COMPOSITIONS FOR FUNCTIONALITY OF ORGANS AND TISSUES
US20110059537A1 (en) 2007-09-20 2011-03-10 Caritas St. Elizabeth's Medical Center Of Boston, Inc. Method for estimating risk of acute kidney injury
AU2009223784A1 (en) 2008-03-08 2009-09-17 Immungene, Inc. Engineered fusion molecules immunotherapy in cancer and inflammatory diseases
CN104020284B (zh) * 2008-10-21 2016-08-24 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
EP2462443A4 (en) * 2009-08-07 2013-01-30 Rules Based Medicine Inc METHODS AND DEVICES FOR DETECTING GLOMERULONEPHRITH AND ASSOCIATED DISORDERS
NZ599105A (en) * 2009-09-21 2014-08-29 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EA201290192A1 (ru) * 2009-11-07 2013-02-28 Астьют Медикал, Инк. Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
MX2012005210A (es) * 2009-11-07 2012-08-03 Astute Medical Inc Metodos y composiciones para diagnostico y pronostico de lesion renal y falla renal.
JP5763098B2 (ja) 2009-12-20 2015-08-12 アスチュート メディカル,インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
US20120156701A1 (en) 2009-12-20 2012-06-21 Joseph Anderberg Methods and compositions for diagnosis and prognosis of renal injury and renal failure
DK2666872T3 (en) * 2010-02-05 2016-07-25 Astute Medical Inc Methods and compositions for the diagnosis and prognosis of renal injury and renal insufficiency
WO2011162821A1 (en) * 2010-06-23 2011-12-29 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN103080743B (zh) 2010-06-23 2015-07-22 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
US20130203074A1 (en) 2010-06-23 2013-08-08 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
UY33492A (es) * 2010-07-09 2012-01-31 Abbott Lab Inmunoglobulinas con dominio variable dual y usos de las mismas
US9410968B2 (en) 2011-04-04 2016-08-09 Universiteit Gent Biomarkers for acute kidney injury
ES2721907T3 (es) * 2011-08-26 2019-08-06 Astute Medical Inc Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal
WO2013086359A1 (en) 2011-12-08 2013-06-13 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2013096740A1 (en) 2011-12-21 2013-06-27 Alere San Diego Inc. Methods and compositions for assigning likelihood of chronic kidney disease progression
US20160003850A1 (en) 2013-02-26 2016-01-07 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX388231B (es) 2014-10-20 2025-03-19 Astute Medical Inc Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal.

Similar Documents

Publication Publication Date Title
JP2022046669A5 (enExample)
NO20076656L (no) Forbedrede immunoassay metoder
JP2022091846A5 (enExample)
JP5553615B2 (ja) プロゾーン現象の低減を示すイムノアッセイ
JP2023100697A (ja) 高濃度の分析物等、分析物を測定するための用量反応曲線の減少信号部分を使用したサンドイッチ型アッセイ
JP2012509477A5 (enExample)
WO2017015132A1 (en) Chips, detectors, and methods of making and using the same
RU2019118625A (ru) Анализ антител
KR102425258B1 (ko) 검체 수집 및 분석 일체형 디바이스, 및 이를 이용한 질병 진단용 정보 제공 방법
JP2020504157A5 (enExample)
Kikkeri et al. A sample-to-answer electrochemical biosensor system for biomarker detection
CN105021827B (zh) 检测血清血管生成素样蛋白2含量的物质在制备检测肝脏炎症和纤维化程度产品中的应用
JP2016539349A (ja) 腎疾患のバイオマーカー
CN204287200U (zh) 尿微量白蛋白免疫层析定量检测试纸条
WO2015192854A2 (en) Methods and tools for predicting steatohepatitis
Hassan et al. Pleural fluid analysis: standstill or a work in progress?
JP2005513504A (ja) 診断方法
JP2021510815A5 (enExample)
CN110398590B (zh) 传感芯片及应用
AU2019212378B2 (en) Multiplex lateral flow assay for differentiating bacterial infections from viral infections
CN104360083A (zh) 一种定量检测类风湿因子、抗链球菌溶血素o、c反应蛋白的检测试剂盒
WO2023122562A3 (en) Reflex test for immunoassay for anti-sars-cov-2 antibodies
CN115980369A (zh) 一种基于炎症反应分型的过敏原筛查试剂盒及其应用
RU2008130888A (ru) Мас-2вр как маркер для диагностики рака желудка
CN202101997U (zh) 快速诊断急性心肌梗死的检测装置